Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Page 1
Long-term changes in bone mineral density in kidney transplant recipients.
Naylor KL, Garg AX, Hodsman AB, Rush DN, Leslie WD. Naylor KL, et al. Among authors: hodsman ab. Transplantation. 2014 Dec 27;98(12):1279-85. doi: 10.1097/TP.0000000000000284. Transplantation. 2014. PMID: 25050472
BACKGROUND: Alterations in bone mineral metabolism occur when kidney function declines and often continue after transplantation. We investigated long-term changes in bone mineral density (BMD) among kidney transplant recipients undergoing routine clinical BMD monitoring an …
BACKGROUND: Alterations in bone mineral metabolism occur when kidney function declines and often continue after transplantation. We investig …
Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions.
Leslie WD, Adler RA, El-Hajj Fuleihan G, Hodsman AB, Kendler DL, McClung M, Miller PD, Watts NB; International Society for Clinical Densitometry. Leslie WD, et al. Among authors: hodsman ab. J Clin Densitom. 2006 Jan-Mar;9(1):22-30. doi: 10.1016/j.jocd.2006.05.004. Epub 2006 May 12. J Clin Densitom. 2006. PMID: 16731428
During the 2005 ISCD Position Development Conference, members of the ISCD Expert Panel in conjunction with the ISCD Scientific Advisory Committee re-addressed these topics and, based upon stringent reviews of best available data, developed ISCD Official Positions that provide gre …
During the 2005 ISCD Position Development Conference, members of the ISCD Expert Panel in conjunction with the ISCD Scientific Advisory Comm …
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK. Hodsman AB, et al. Endocr Rev. 2005 Aug;26(5):688-703. doi: 10.1210/er.2004-0006. Epub 2005 Mar 15. Endocr Rev. 2005. PMID: 15769903 Review.
Teriparatide should be considered as treatment for postmenopausal women and men with severe osteoporosis, as well as for patients with established glucocorticoid-induced osteoporosis who require long-term steroid treatment. Teriparatide should also be considered for the ma …
Teriparatide should be considered as treatment for postmenopausal women and men with severe osteoporosis, as well as for patients with estab …
Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?
Hodsman AB. Hodsman AB. Perit Dial Int. 2001;21 Suppl 3:S247-55. Perit Dial Int. 2001. PMID: 11887831 Review.
The term "osteoporosis" must be applied with caution to the uremic population, which has a complex range of metabolic bone disease. ...
The term "osteoporosis" must be applied with caution to the uremic population, which has a complex range of metabolic bone disease. . …
Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
Crilly RG, Sebaldt RJ, Hodsman AB, Adachi JD, Brown JP, Goldsmith CH, Hanley DA, Olszynski WO, Ste-Marie LG, Stephenson GF. Crilly RG, et al. Among authors: hodsman ab. Osteoporos Int. 2000;11(7):607-14. doi: 10.1007/s001980070082. Osteoporos Int. 2000. PMID: 11069195
We investigated whether an increase in lumbar spine bone mineral density (LS BMD) at 6 months or at 12 months could predict the response to intermittent cyclical therapy (ICT) with etidronate, defined in one of two ways: (i) an increase in LS BMD at 24 months (improvement) or (ii …
We investigated whether an increase in lumbar spine bone mineral density (LS BMD) at 6 months or at 12 months could predict the response to …
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry.
Miller PD, Bonnick SL, Rosen CJ, Altman RD, Avioli LV, Dequeker J, Felsenberg D, Genant HK, Gennari C, Harper KD, Hodsman AB, Kleerekoper M, Mautalen CA, McClung MR, Meunier PJ, Nelson DA, Peel NF, Raisz LG, Recker RR, Utian WH, Wasnich RD, Watts NB. Miller PD, et al. Among authors: hodsman ab. Semin Arthritis Rheum. 1996 Jun;25(6):361-72. doi: 10.1016/s0049-0172(96)80001-1. Semin Arthritis Rheum. 1996. PMID: 8792508 Review.
Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial mea …
Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebr …
Long-term gonadotropin-releasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women.
Sugimoto AK, Hodsman AB, Nisker JA. Sugimoto AK, et al. Among authors: hodsman ab. Fertil Steril. 1993 Oct;60(4):672-4. doi: 10.1016/s0015-0282(16)56220-7. Fertil Steril. 1993. PMID: 8405523 Free article.
If indeed younger women do not receive bone protection from standard postmenopausal hormone replacement, these women may also be at increased risk for heart disease, urogenital atrophy, and other effects of long-term hypoestrogenism with 0.625 mg of CE add-back. We recomme …
If indeed younger women do not receive bone protection from standard postmenopausal hormone replacement, these women may also be at increase …
Effects of dose and dosing schedule of inhaled budesonide on bone turnover.
Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Toogood JH, et al. Among authors: hodsman ab. J Allergy Clin Immunol. 1991 Oct;88(4):572-80. doi: 10.1016/0091-6749(91)90150-m. J Allergy Clin Immunol. 1991. PMID: 1918724 Clinical Trial.
Of concern is the possibility of serious bone complications resulting from the long-term use of inhaled steroid, particularly in growing children or patients in whom other risk factors for osteoporosis are present. ...
Of concern is the possibility of serious bone complications resulting from the long-term use of inhaled steroid, particularly in grow …
Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin.
Hodsman AB, Toogood JH, Jennings B, Fraher LJ, Baskerville JC. Hodsman AB, et al. J Clin Endocrinol Metab. 1991 Mar;72(3):530-40. doi: 10.1210/jcem-72-3-530. J Clin Endocrinol Metab. 1991. PMID: 1997509 Clinical Trial.
None of these changes was seen during budesonide therapy. There are as yet no data for these variables after long term use of inhaled budesonide in asthmatic patients, but our acute studies suggest that this potent topical glucocorticoid may have considerably less impact o …
None of these changes was seen during budesonide therapy. There are as yet no data for these variables after long term use of inhaled …
14 results